RXRα suppression drives hepatic metabolic and immune dysfunction in sepsis

Read full text
Authors: Matyas Jelinek, Jolien Vandewalle, Marah Heyerick, Tineke Vanderhaeghen, Céline Van Dender, Steven Timmermans, Madeleine Hellemans, Daria Fijałkowska, H. de Rooster, Martin Guilliams, Karolien De Bosscher, Claude Libert
Cited by: 1
References: 63

Abstract

Sepsis is a life-threatening condition in which a dysregulated host response to infection leads to organ dysfunction and metabolic and immune failure. We identify hepatocyte retinoid X receptor α (RXRα) as a key integrator of host resilience during polymicrobial sepsis. RXRα is transcriptionally regulated by hepatocyte nuclear factor 4α (HNF4α), and sepsis rapidly decreases RXRα mRNA and protein levels. Transcriptomic analyses show that the septic liver becomes partially resistant to pharmacological activation of RXRα with bexarotene. Prophylactic- but not therapeutic- bexarotene improves survival by preserving metabolic stability and enhancing bacterial clearance. In hepatocyte-specific inducible RXRα-deficient mice, this protection is lost, confirming dependence on hepatocyte RXRα. Loss of RXRα in hepatocytes reduces Kupffer cell numbers, resulting in bacterial dissemination and mortality, a phenotype reproduced in a genetic model of selective Kupffer cell ablation. Overall, RXRα maintains the hepatic macrophage niche, linking hepatocellular transcriptional competence to systemic antibacterial defense.

Fields of Study & Subjects

Immune Response and Inflammation Neutrophil Myeloperoxidase and Oxidative Mechanisms Retinoids in leukemia and cellular processes

Publication details

Journal / source
EMBO Molecular Medicine
Publisher
Springer Science and Business Media LLC
Volume
18
Issue
8
Pages
3318–3344
Publication date
16 July 2026
Language
EN